Thinking of joining a study?

Register your interest

NCT05549869 | Not yet recruiting | Vitiligo


Assessment of Serum Leptin in Vitiligo Patients
Sponsor:

Sohag University

Information provided by (Responsible Party):

Zaghloul Amin medicine

Brief Summary:

Evaluation of serum leptin in vitiligo patients and control Assessing its correlation to the body mass index and disease dermographic data .

Condition or disease

Vitiligo

Intervention/treatment

serum leptin

Phase

Not Applicable

Detailed Description:

, leptin is supposed to contribute to vitiligo pathogenesis through promoting the release of pro-inflammatory mediators such as tumor necrosis factor α "TNF," IL-2 and IL-6, as well as enhancing cytotoxic T cells "CD8" recruitment and inhibiting the functions of regulatory T cells "Tregs". Leptin can also aid in induction of oxidative stress by activating nicotinamide adenine dinucleotide phosphate (NADPH) oxidase• Venous blood samples will be taken from patients and controls to evaluate serum leptin: Morning samples will be taken after 12-h overnight fast in plain vacutainer tubes and directly centrifuged (1098 g for 15 min). Sera will be then collected in plain, capped, 5 ml centrifuge tubes "Eppendorf" and freezed at -20ᵒC in a well-monitored freezer until the analysis is performed• Serum leptin will be quantitatively assessed in vitro using DRG leptin Sandwich Enzyme Linked Immuno-Sorbent Assay "ELISA". ELISA will be performed according to manufacturer's guidelines where each run included a standard curve. Using the mean absorbance value for each sample, the corresponding concentration from the standard curve will be determined.}}

Study Type : Interventional
Estimated Enrollment : 400 participants
Masking : None (Open Label)
Primary Purpose : Treatment
Official Title : Assessment of Serum Leptin in Vitiligo Patients
Actual Study Start Date : November 2022
Estimated Primary Completion Date : September 2023
Estimated Study Completion Date : September 2023
Arm Intervention/treatment

Active Comparator: group A

obese with vitiligo

Diagnostic Test: serum leptin

Active Comparator: group b

obese without vitiligo

Diagnostic Test: serum leptin

Active Comparator: group C

non obese with vitiligo

Diagnostic Test: serum leptin

Active Comparator: group D

non obese without vitiligo

Diagnostic Test: serum leptin

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • All patients with vitiligo who are above the age of 18 years
Exclusion Criteria
  • Patients with other autoimmune diseases

Assessment of Serum Leptin in Vitiligo Patients

Location Details


Please Choose a site



Assessment of Serum Leptin in Vitiligo Patients

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Egypt,

Sohag University Hospital

Sohag, Egypt,

Loading...